JPRN-UMIN000039847尚未招募未知
Beauty & healThy (BeauThy) Project Risks of lifestyle in normal weight obese university students - Beauty & healThy (BeauThy) Project Risks of lifestyle in normal weight obese university students
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Under treatment or have history of cardiovascular diseases and limited ones' physical activity by doctors. 2. Under treatment of diabetes mellitus, kidney diseases, respiratory diseases, orthopedic diseases, congenital diseases, neuromuscular disease and limited ones' physical activity by doctors. 3. The period of pregnancy or have possibility of it. 4. Within three months of childbirth. 5. Participants of intervention programs to reduce body fat rate or to improve body composition.
研究者
相似试验
招募中
Unknown
Addressing safety, quality and cost of care through a novel, telehealth, outpatient transitional care model – the TTOMMI trialpreventable hospital readmissionmultimorbidityPublic Health - Health service researchACTRN12624000142538The University of Adelaide200
已完成
4 期
A study to explore the efficacy of millets in athletic populatioCTRI/2023/10/059332Ministry of Agriculture and Farmers Welfare120
尚未招募
不适用
Health and wellbeingautonoom zenuwstelsel en HPA-as functie, geen aandoeningHeart and hormones10014136NL-OMON32847Vrije Universiteit200
进行中（未招募）
1 期
A long term extension study looking at the efficacy and safety of teduglutide in paediatric patients suffering from short bowel syndrome who took part in study TED-C14-006 or SHP633-301Short Bowel SyndromeEUCTR2016-000849-30-FIShire Human Genetic Therapies, Inc.50
进行中（未招募）
1 期
A long term extension study looking at the efficacy and safety of teduglutide in paediatric patients suffering from short bowel syndrome who took part in study TED-C14-006MedDRA version: 20.0Level: PTClassification code 10049416Term: Short-bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersShort Bowel SyndromeEUCTR2016-000849-30-BEShire Human Genetic Therapies, Inc.61